gip/glp-1 agonists Science Behind GLP 1 GIP and Glucagon Receptor for Obesity Research | News & Announcements Understand GLP-1/GIP Dual Agonist Tirzepatide
Description
SUMMARYIncretin therapy is based on the antidiabetic actions of the incretin hormone GLP-1
Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.
Survodutide also reduced waist circumference, an indicator of metabolic health.
Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020
We aimed to e...
Join our exclusive pre-launch waitlist today.
